HSR&D Research Career Scientist Award

高铁

基本信息

  • 批准号:
    10248714
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-10-01 至 2026-09-30
  • 项目状态:
    未结题

项目摘要

Behavioral health (BH) conditions, including mental health and substance use disorders, remain common and persistent among Veterans Health Administration (VHA) patients. Several VHA key priority areas coincide with BH conditions, including disability, overdose, suicide, and women's health. VHA remains a national leader in providing high-quality BH treatment and serves as an early responder to policies and programs designed to improve health and wellbeing for individuals experiencing these conditions. VHA must develop and evaluate new strategies to manage and resolve the complicated array of problems facing Veterans with BH conditions and their providers. Kara Zivin, PhD, MS, MA has focused on improving VHA BH services using used mixed methods research and evaluation approaches. The three primary thematic aims of her work include: 1) to continue research to evaluate the impacts of health policies and system initiatives on outcomes among Veterans with BH conditions, leading to intervention development, implementation, dissemination, and targeted policymaking; 2) to extend research to improve Veteran functional outcomes including disability and employment among those with BH conditions and enhance VHA clinician wellbeing; and 3), to develop and lead women's health research to improve Veterans' perinatal BH. These three thematic areas directly relate to positive treatment outcomes, including overall function and wellbeing, and reducing the likelihood of adverse events among Veterans with BH conditions. Dr. Zivin's has demonstrated her contributions to these areas through her externally funded research with support from VA Health Services Research and Development (HSR&D), National Institutes of Health (NIH), and Michigan Department of Health and Human Services (MDHHS) among others in addition to over 160 peer- reviewed scientific publications. Dr. Zivin has actively mentored ten early career investigators and/or trainees within the VA and has served in key leadership and service roles locally within the Ann Arbor VA Center of Innovation (COIN) and nationally within the VHA. Given her active and productive research portfolio and demonstrated commitment to mentoring colleagues in developing VHA research careers, Dr. Zivin is a strong candidate for a Health Services Research Career Scientist Award. The proposed Research Career Scientist Award will support her continued research, an expanded role in mentorship and training of the next generation of HSR&D researchers, and targeted VHA service designed to enhance and extend the reach and impact of her research and mentoring. Her research portfolio has the potential to address some of the most critical and vexing BH-related priorities in VHA and improve care for some of the most challenging and highest-risk Veterans treated within the VHA system.
行为健康 (BH) 状况,包括心理健康和药物滥用障碍,仍然很常见,并且 退伍军人健康管理局 (VHA) 患者中持续存在。几个 VHA 关键优先领域与 BH 状况,包括残疾、服药过量、自杀和妇女健康。 VHA 仍然处于全国领先地位 提供高质量的 BH 治疗,并作为旨在实现以下目标的政策和计划的早期响应者: 改善患有这些疾病的个人的健康和福祉。 VHA 必须开发和评估 管理和解决患有 BH 状况的退伍军人面临的一系列复杂问题的新策略 他们的提供者。 Kara Zivin 博士、硕士、硕士致力于使用混合方法研究和改进 VHA BH 服务 评价方法。她工作的三个主要主题目标包括:1)继续研究以评估 卫生政策和系统举措对患有 BH 疾病的退伍军人的结果的影响,导致 干预的制定、实施、传播和有针对性的政策制定; 2)扩展研究 改善退伍军人的功能结果,包括患有 BH 疾病的退伍军人的残疾和就业 提高 VHA 临床医生的福祉; 3) 发展和领导女性健康研究,以改善退伍军人的健康状况 围产期 BH。这三个主题领域与积极的治疗结果直接相关,包括总体治疗结果 功能和健康,并减少患有 BH 病症的退伍军人发生不良事件的可能性。 Zivin 博士通过外部资助的研究证明了她对这些领域的贡献 来自 VA 卫生服务研究与发展 (HSR&D)、国立卫生研究院 (NIH) 和 密歇根州卫生与公众服务部 (MDHHS) 以及其他 160 多个同行 审查了科学出版物。 Zivin 博士积极指导了十名早期职业调查员和/或实习生 在 VA 内,并在安娜堡 VA 中心当地担任关键领导和服务职务 创新 (COIN) 和 VHA 内的全国范围。 鉴于她积极而富有成效的研究成果,并表现出对指导同事的承诺 Zivin 博士致力于发展 VHA 研究职业,是健康服务研究职业科学家的有力候选人 奖。拟议的研究职业科学家奖将支持她继续研究,扩大她在 下一代 HSR&D 研究人员的指导和培训,以及旨在 加强和扩大她的研究和指导的范围和影响。她的研究组合有潜力 解决 VHA 中一些最关键和最令人烦恼的 BH 相关优先事项,并改善对一些患者的护理 在 VHA 系统中接受治疗的最具挑战性和最高风险的退伍军人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kara Zivin其他文献

Kara Zivin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kara Zivin', 18)}}的其他基金

HSR&D Research Career Scientist Award
高铁
  • 批准号:
    10489275
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Disparities in utilization and delivery outcomes for women with perinatal mood and anxiety disorders (PMAD): groundwork for state policymaking
患有围产期情绪和焦虑症 (PMAD) 的妇女在利用和分娩结果方面的差异:国家政策制定的基础
  • 批准号:
    10305975
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Disparities in utilization and delivery outcomes for women with perinatal mood and anxiety disorders (PMAD): groundwork for state policymaking
患有围产期情绪和焦虑症 (PMAD) 的妇女在利用和分娩结果方面的差异:国家政策制定的基础
  • 批准号:
    10618967
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
  • 批准号:
    10409775
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Caring for the caregiver: predictors and consequences of VA mental health provider burnout
照顾看护者:退伍军人管理局心理健康提供者倦怠的预测因素和后果
  • 批准号:
    9710109
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
  • 批准号:
    10197277
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Relationship between mental health coverage and outcomes for privately insured women with perinatal mood and anxiety disorders (PMAD)
患有围产期情绪和焦虑症 (PMAD) 的私人受保女性的心理健康保险与结果之间的关系
  • 批准号:
    10197811
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Caring for the caregiver: predictors and consequences of VA mental health provider burnout
照顾看护者:退伍军人管理局心理健康提供者倦怠的预测因素和后果
  • 批准号:
    10570155
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Unintended Consequences: The Impact of VA Antipsychotic Reduction Efforts in Dementia
意想不到的后果:减少 VA 抗精神病药物治疗对痴呆症的影响
  • 批准号:
    9873826
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Unintended Consequences: The Impact of VA Antipsychotic Reduction Efforts in Dementia
意想不到的后果:减少 VA 抗精神病药物治疗对痴呆症的影响
  • 批准号:
    10308378
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了